Daniel Kredentser

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial

Éric Pujade-Lauraine, Jonathan A. Ledermann, Frédèric Selle et al. · The Lancet Oncology · 2017 · 1.9K citations

Pharmacy, Oncology, Pharmacotherapy +14

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda, Anne Floquet, Jonathan A. Ledermann et al. · The Lancet Oncology · 2021 · 416 citations · Full text

Medicine, Oncology, Pharmacology +15

Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma

John H. Malfetano, Daniel Kredentser, Mary Cunningham et al. · Cancer · 1993 · 59 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Vulvar Malignant Melanoma Associated With Human Papillomavirus DNA

Angela Rohwedder, Brooke Philips, John H. Malfetano et al. · American Journal of Dermatopathology · 2002 · 57 citations

Medicine, Dermatology, Pathology +15

Percutaneous Gastrostomy for Decompression in Patients with Advanced Gynecologic Malignancies

MARY JADHONCUNNINGHAM, Cheryl Bromberg, Daniel Kredentser et al. · Gynecologic Oncology · 1995 · 41 citations

Medicine, Oncology, Surgery +13